Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A Final results from the ASPIRE extension study

Simple item page
dc.citation.doi10.1111/HAE.13953
dc.citation.epage502
dc.citation.spage494
dc.contributor.authorBeatrice Nolan
dc.contributor.authorJohnny Mahlangu
dc.contributor.authorIngrid Pabinger
dc.contributor.authorGuy Young
dc.contributor.authorBarbara Konkle
dc.contributor.authorA Et Al
dc.date.accessioned2023-10-06T12:02:43Z
dc.date.available2023-10-06T12:02:43Z
dc.identifier.citationWOS
dc.identifier.issn1351-8216
dc.identifier.urihttps://hdl.handle.net/10539/36425
dc.journal.titleHAEMOPHILIA
dc.journal.volume26
dc.titleRecombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A Final results from the ASPIRE extension study
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
479.98 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download
Collections
Wits Research Outputs